Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

Urology

Volumn 49, Issue 6, 1997, Pages 839-845

  Andersen, Jens T ^a   Curtis Nickel, J ^a   Marshall, Villis R ^a   Schulman, Claude C ^a   Boyle, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; URINARY TRACT INFECTION; URINE RETENTION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ENZYME INHIBITORS; FINASTERIDE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, OPERATIVE; URINARY RETENTION;

EID: 0342618512     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00185-4     Document Type: Article

References (21)

1. Sagnier P-P, Girman CJ, Garraway M, Kumamoto Y, Lieber MM, Richard F, Macfarlane G, Guess HA, Jacobsen SJ, Tsukamoto T, et al. International comparison of the community prevalence of symptoms of prostatism in four countries. Eur Urol. 29:1996;15-20.
2. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate. 3:1990;61-74.
3. Boyle P, Maisonneuve P, Steg A. Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph. J Urol. 155:1996;176-180.
4. McConnell JD. The pathophysiology of benign prostatic hyperplasia. J Androl. 12:1991;356-363.
5. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism type 2: decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 291:1974;944-949.
6. Stoner E. The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. J Urol. 147:1992;1298-1302.
7. Gormley GJ. Finasteride: a clinical review. Biomed Pharmacother. 49:1995;319-324.
8. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley JI, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 327:1992;1185-1191.
9. Stoner E. Finasteride (MK-906) in the treatment of benign prostatic hyperplasia. Prostate. 22:1993;291-299.
10. Andersen JT, Ekman P, Wolf H, Beisland HO, Johansson JE, Kontturi M, Lehtonen T, Tveter K. Can finasteride reverse the progress of benign prostatic hyperplasia? A 2-year placebo-controlled study. Urology. 46:1995;631-637.
11. Nickel JC, Fradet Y, Boake RC, Pommerville PJ, Perreault J-P, Afridi SK, Elhilali MM. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). Can Med Assoc J. 155:1996;1251-1259.
12. Boyle P, Gould AL, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology. 48:1996;398-405.
13. Marberger JM, Marshall VR, Vela Navarette R, Schulman CC. Continuous improvement with finasteride in symptomatic benign prostatic hyperplasia. J Urol. 157:1997;133. (suppl).
14. Bolognese JA, Kozloff RC, Kunik SC, Grino PB, Patrick DL, Stoner E. Validation of a symptoms questionnaire for benign prostatic hyperplasia. Prostate. 21:1992;247-254.
15. Lepor H, Stoner E. Long-term results of medical therapies for benign prostatic hyperplasia. Curr Opin Urol. 5:1995;18-24.
16. ®: 5-year experience. Eur Urol. 28:1995;304-309.
17. Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 153:1995;1510-1515.
18. Jacobsen SJ, Jacobsen DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: risk factors for urinary retention. J Urol. 157:1997;191. (suppl).
19. Malone PR, Cook A, Edmondson R, Gill MW, Shearer J. Prostatectomy: patients' perception and long-term follow-up. Br J Urol. 61:1988;234-238.
20. Hastie KJ, Dickinson AJ, Ahmad R, Moisey CU. Acute urinary retention of urine: is trial without catheter justified? J R Coll Surg Edinb. 35:1990;225-227.
21. McConnell JD, Roehrborn CG. Patient selection and symptom evaluation. Chisholm GD. Handbook on Benign Prostatic Hyperplasia. 1994;167-182 Raven Press, New York.